J Res Med Sci. 2014 Dec;19(12):1145-9.

The diagnostic role of cervico-vaginal fluid interleukins-1α in endometriosis: A case-control study.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Farahnaz Mardanian, Zahra Sheikh-Soleimani

PMID: 25709655 PMCID: PMC4333522

Abstract

BACKGROUND: Endometriosis is a chronic and progressive gynecological disorder and is manifest by dysmenorrhea and a major cause of infertility and chronic pelvic pain. The study was designed to compare the value of cervico-vaginal fluid of interleukin-1α (IL-1α) in patients with and without endometriosis.

MATERIALS AND METHODS: Fifty women were assessed in this case control study. The case group included 25 patients with endometriosis. The control group included 25 women without any evidence of endometriosis or any other genital disease. Endometriosis was confirmed by laparoscopy and histopathological examination. Cervico-vaginal fluid samples were obtained from patients during the follicular phase and preup surgery to assess the levels of IL-1α in cervico-vaginal fluid. The level of IL-1α was assessed using commercially available Avi Bionhuman Enzyme-Linked Immunosorbent Assay kits (FIN-01720, Vantaa, Finland) for IL-1α. Receiver-operator curve analysis was used to estimate the power of IL-1α to distinguish subjects with endometriosis from controls.

RESULTS: The cervico-vaginal fluid level of IL-1α in cases was 210.44 ± 40.11 pg/mL and in controls was 54.28 ± 25.73 pg/mL, the differences between two groups was statistically significant (P < 0.0001). The cut-off point for cervico-vaginal fluid IL-1 for endometriosis was 105 pg/mL, with a sensitivity of 100% (95% confidence interval [CI]: 86.2-100), and specificity of 100% (95% CI: 86.2-100).

CONCLUSION: Results show a significant increase in the cervico-vaginal fluid levels of IL-1α, in women with endometriosis, that it can be a useful marker in the diagnosis of endometriosis.

Keywords: Cervico-vaginal fluid; cytokine; endometriosis; interleukin-1α; interleukins

References

1. J Obstet Gynaecol Res. 2012 Oct;38(10 ):1245-53 - PubMed
2. Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):245-63 - PubMed
3. J Reprod Immunol. 2010 Mar;84(2):199-205 - PubMed
4. Am J Reprod Immunol. 2003 Jul;50(1):48-59 - PubMed
5. Fertil Steril. 2012 Jun;97(6):1380-6.e1 - PubMed
6. J Proteome Res. 2007 Dec;6(12):4549-55 - PubMed
7. Fertil Steril. 2011 Mar 15;95(4):1284-90 - PubMed
8. J Reprod Immunol. 2011 Dec;92(1-2):68-73 - PubMed
9. Am J Reprod Immunol. 2003 May;49(5):285-96 - PubMed
10. N Engl J Med. 2010 Jun 24;362(25):2389-98 - PubMed
11. Hum Reprod. 2009 Apr;24(4):835-41 - PubMed
12. Fertil Steril. 2008 Jun;89(6):1618-24 - PubMed
13. Mol Hum Reprod. 2005 Jan;11(1):29-34 - PubMed
14. Eur J Obstet Gynecol Reprod Biol. 2000 Feb;88(2):117-9 - PubMed
15. J Obstet Gynaecol Res. 2007 Aug;33(4):490-5 - PubMed
16. Proteomics. 2006 Dec;6(23):6326-53 - PubMed
17. Am J Reprod Immunol. 2000 Oct;44(4):231-5 - PubMed
18. Am J Obstet Gynecol. 1992 Jul;167(1):265-70 - PubMed
19. Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):95-103 - PubMed
20. Am J Obstet Gynecol. 2001 Jun;184(7):1407-11; discussion 1411-3 - PubMed
21. Am Fam Physician. 2006 Aug 15;74(4):594-600 - PubMed
22. Fertil Steril. 2006 Nov;86(5):1307-9; discussion 1317 - PubMed
23. Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):215-7 - PubMed
24. Proteome Sci. 2010 Dec 08;8:63 - PubMed
25. Fertil Steril. 1992 Mar;57(3):535-42 - PubMed
26. Am J Obstet Gynecol. 1997 Mar;176(3):593-7 - PubMed
27. Expert Opin Med Diagn. 2008 Jul;2(7):741-52 - PubMed
28. Med Hypotheses. 2003 Jan;60(1):84-8 - PubMed
29. Mol Cell Proteomics. 2005 Apr;4(4):409-18 - PubMed
30. Genome Res. 2003 Sep;13(9):2129-41 - PubMed
31. Reprod Biomed Online. 2006 Jul;13(1):58-64 - PubMed

Publication Types

• Journal Article